PortfoliosLab logoPortfoliosLab logo
LEXX vs. AVGO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LEXX vs. AVGO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lexaria Bioscience Corp. (LEXX) and Broadcom Inc. (AVGO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LEXX achieves a -36.63% return, which is significantly lower than AVGO's 12.89% return. Over the past 10 years, LEXX has underperformed AVGO with an annualized return of -20.27%, while AVGO has yielded a comparatively higher 40.86% annualized return.


LEXX

1D
-1.34%
1M
-30.19%
6M
-50.11%
YTD
-36.63%
1Y
-54.02%
3Y*
-22.65%
5Y*
-42.52%
10Y*
-20.27%
ALL TIME*
-18.25%

AVGO

1D
0.37%
1M
8.00%
6M
17.93%
YTD
12.89%
1Y
35.86%
3Y*
63.70%
5Y*
54.52%
10Y*
40.86%
ALL TIME*
40.74%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$7.09B$8.00B$10.48B
$80.49K$63.66K$60.90K

LEXX vs. AVGO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
LEXX
Lexaria Bioscience Corp.
-36.63%-70.62%68.00%-49.19%-38.96%-46.12%-34.39%-59.14%-44.97%445.16%
AVGO
Broadcom Inc.
12.89%50.63%110.49%104.18%-13.27%56.48%44.88%29.05%2.18%48.19%

Correlation

The correlation between LEXX and AVGO is 0.10, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.10

Correlation (3Y)
Balances recent behavior with more history.

0.07

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.11

Correlation (10Y)
Provides a long-term view across more market conditions.

0.09

Correlation (All Time)
Calculated using the full available price history since May 12, 2016

0.09

Fundamentals

Market Cap

LEXX:

$9.69M

AVGO:

$1.85T

EPS

LEXX:

-$0.34

AVGO:

$6.01

PS Ratio

LEXX:

45.44

AVGO:

25.16

PB Ratio

LEXX:

2.05

AVGO:

21.65

Total Revenue (TTM)

LEXX:

$194.00K

AVGO:

$75.47B

Gross Profit (TTM)

LEXX:

$194.00K

AVGO:

$50.53B

EBITDA (TTM)

LEXX:

-$7.68M

AVGO:

$42.03B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LEXX vs. AVGO — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

LEXX
LEXX Risk / Return Rank: 2020
Overall Rank
LEXX Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
LEXX Sortino Ratio Rank: 2626
Sortino Ratio Rank
LEXX Omega Ratio Rank: 2525
Omega Ratio Rank
LEXX Calmar Ratio Rank: 1515
Calmar Ratio Rank
LEXX Martin Ratio Rank: 1515
Martin Ratio Rank

AVGO
AVGO Risk / Return Rank: 6767
Overall Rank
AVGO Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
AVGO Sortino Ratio Rank: 6666
Sortino Ratio Rank
AVGO Omega Ratio Rank: 6464
Omega Ratio Rank
AVGO Calmar Ratio Rank: 7070
Calmar Ratio Rank
AVGO Martin Ratio Rank: 6767
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

LEXX vs. AVGO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lexaria Bioscience Corp. (LEXX) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


LEXXAVGODifference
Sharpe ratioReturn per unit of total volatility

-1.24

Sortino ratioReturn per unit of downside risk

-1.54

Omega ratioGain probability vs. loss probability

0.96

1.16

-0.20

Calmar ratioReturn relative to maximum drawdown

-0.76

1.17

-1.94

Martin ratioReturn relative to average drawdown

-1.21

2.34

-3.56

LEXX vs. AVGO - Sharpe Ratio Comparison

The current LEXX Sharpe Ratio is -0.52, which is lower than the AVGO Sharpe Ratio of 0.71. The chart below compares the historical Sharpe Ratios of LEXX and AVGO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

LEXX vs. AVGO - Drawdown Comparison

The maximum LEXX drawdown since its inception was -99.45%, which is greater than AVGO's maximum drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for LEXX and AVGO.


Loading charts...

Drawdown Indicators


LEXXAVGODifference

Max Drawdown

Largest peak-to-trough decline

-99.45%

-48.30%

-51.15%

Max Drawdown (1Y)

Largest decline over 1 year

-74.44%

-28.67%

-45.77%

Max Drawdown (3Y)

Largest decline over 3 years

-93.74%

-41.15%

-52.59%

Max Drawdown (5Y)

Largest decline over 5 years

-94.43%

-41.15%

-53.28%

Max Drawdown (10Y)

Largest decline over 10 years

-99.45%

-48.30%

-51.15%

Current Drawdown

Current decline from peak

-99.45%

-19.04%

-80.41%

Average Drawdown

Average peak-to-trough decline

-74.77%

-8.08%

-66.69%

Ulcer Index

Depth and duration of drawdowns from previous peaks

46.64%

14.34%

+32.30%

Volatility

LEXX vs. AVGO - Volatility Comparison

Lexaria Bioscience Corp. (LEXX) has a higher volatility of 38.95% compared to Broadcom Inc. (AVGO) at 12.66%. This indicates that LEXX's price experiences larger fluctuations and is considered to be riskier than AVGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LEXXAVGODifference

Volatility (1M)

Calculated over the trailing 1-month period

38.95%

12.66%

+26.29%

Volatility (6M)

Calculated over the trailing 6-month period

68.03%

34.37%

+33.66%

Volatility (1Y)

Calculated over the trailing 1-year period

108.09%

47.48%

+60.61%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

92.25%

43.94%

+48.31%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

103.06%

39.72%

+63.34%

Dividends

LEXX vs. AVGO - Dividend Comparison

LEXX has not paid dividends to shareholders, while AVGO's dividend yield for the trailing twelve months is around 0.65%.


PositionTTM20252024202320222021202020192018201720162015
AVGO
Broadcom Inc.
0.65%0.70%0.94%1.71%3.02%2.24%3.05%3.54%3.11%1.87%1.43%1.13%
LEXX
Lexaria Bioscience Corp.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

LEXX vs. AVGO - Financials Comparison

This section allows you to compare key financial metrics between Lexaria Bioscience Corp. and Broadcom Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


LEXX and AVGO have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LEXX has higher volatility (38.95%) compared to AVGO (12.66%). In terms of maximum drawdown, LEXX dropped -99.45% vs AVGO's -48.30%.

AVGO currently has the higher Sharpe Ratio (0.71 vs -0.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LEXX and AVGO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer